BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, Sternfeld B, Williams OD, Lewis CE, Azziz R, Schwartz SM, Wellons MF. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study. Arterioscler Thromb Vasc Biol 2014;34:2688-94. [PMID: 25359859 DOI: 10.1161/ATVBAHA.114.304136] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Prabakaran S, Vitter S, Lundberg G. Cardiovascular Disease in Women Update: Ischemia, Diagnostic Testing, and Menopause Hormone Therapy. Endocr Pract 2021:S1530-891X(21)01291-X. [PMID: 34974184 DOI: 10.1016/j.eprac.2021.10.007] [Reference Citation Analysis]
2 Merz CN, Shaw LJ, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-DeHoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ. Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome. J Womens Health (Larchmt) 2016;25:875-81. [PMID: 27267867 DOI: 10.1089/jwh.2015.5441] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
3 Zoet GA, Meun C, Benschop L, Boersma E, Budde RPJ, Fauser BCJM, de Groot CJM, van der Lugt A, Maas AHEM, Moons KGM, Roeters van Lennep JE, Roos-Hesselink JW, Steegers EAP, van Rijn BB, Laven JSE, Franx A, Velthuis BK. Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study. BMC Womens Health 2017;17:60. [PMID: 28784118 DOI: 10.1186/s12905-017-0415-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
4 Boese AC, Kim SC, Yin KJ, Lee JP, Hamblin MH. Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. Am J Physiol Heart Circ Physiol 2017;313:H524-45. [PMID: 28626075 DOI: 10.1152/ajpheart.00217.2016] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 15.0] [Reference Citation Analysis]
5 Kim AS, Wild RA. A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome. Journal of Women's Health. [DOI: 10.1089/jwh.2022.0160] [Reference Citation Analysis]
6 Patel SS, Truong U, King M, Ferland A, Moreau KL, Dorosz J, Hokanson JE, Wang H, Kinney GL, Maahs DM, Eckel RH, Nadeau KJ, Cree-Green M. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers. Vasc Med 2017;22:85-95. [PMID: 28095749 DOI: 10.1177/1358863X16682107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
7 Osibogun O, Ogunmoroti O, Kolade OB, Hays AG, Okunrintemi V, Minhas AS, Gulati M, Michos ED. A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification. J Womens Health (Larchmt) 2022. [PMID: 35575750 DOI: 10.1089/jwh.2021.0608] [Reference Citation Analysis]
8 Shah D, Rasool S. Polycystic Ovary Syndrome (PCOS) Transition at Menopause. J Midlife Health 2021;12:30-2. [PMID: 34188423 DOI: 10.4103/jmh.jmh_37_21] [Reference Citation Analysis]
9 Gao L, Cao JT, Liang Y, Zhao YC, Lin XH, Li XC, Tan YJ, Li JY, Zhou CL, Xu HY, Sheng JZ, Huang HF. Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome. Endocrine 2016;52:363-73. [PMID: 26578366 DOI: 10.1007/s12020-015-0797-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
10 Kim C, Aroda VR, Goldberg RB, Younes N, Edelstein SL, Carrion-Petersen M, Ehrmann DA; Diabetes Prevention Program Outcomes Study Group. Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program. J Clin Endocrinol Metab 2018;103:486-96. [PMID: 29220533 DOI: 10.1210/jc.2017-01829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Kim C, Puterman E, Hou L, Slaughter JC, Terry JG, Wellons MF. Antimüllerian hormone and leukocyte aging markers in the Coronary Artery Risk Development in Young Adults study. Fertility and Sterility 2022. [DOI: 10.1016/j.fertnstert.2022.03.021] [Reference Citation Analysis]
12 Song JS, Wang RS, Leopold JA, Loscalzo J. Network determinants of cardiovascular calcification and repositioned drug treatments. FASEB J 2020;34:11087-100. [PMID: 32638415 DOI: 10.1096/fj.202001062R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Ding DC, Tsai IJ, Wang JH, Lin SZ, Sung FC. Coronary artery disease risk in young women with polycystic ovary syndrome. Oncotarget 2018;9:8756-64. [PMID: 29492235 DOI: 10.18632/oncotarget.23985] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
14 Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol 2020;18:23. [PMID: 32183820 DOI: 10.1186/s12958-020-00576-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
15 Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, Michos ED. Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease. Fertil Steril 2022;117:924-35. [PMID: 35512976 DOI: 10.1016/j.fertnstert.2022.03.009] [Reference Citation Analysis]
16 Zhang J, Xu JH, Qu QQ, Zhong GQ. Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies. Front Cardiovasc Med 2020;7:552421. [PMID: 33282917 DOI: 10.3389/fcvm.2020.552421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Garg N, Dharmalingam M, Prabhu V, Murthy NS. Carotid intimo-medial thickness: A predictor for cardiovascular disorder in patients with polycystic ovarian syndrome in the South Indian population. Indian J Endocrinol Metab 2016;20:662-6. [PMID: 27730077 DOI: 10.4103/2230-8210.190552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 O'Kelly AC, Michos ED, Shufelt CL, Vermunt JV, Minissian MB, Quesada O, Smith GN, Rich-Edwards JW, Garovic VD, El Khoudary SR, Honigberg MC. Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women. Circ Res 2022;130:652-72. [PMID: 35175837 DOI: 10.1161/CIRCRESAHA.121.319895] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Stone T, Stachenfeld NS. Pathophysiological effects of androgens on the female vascular system. Biol Sex Differ. 2020;11:45. [PMID: 32727622 DOI: 10.1186/s13293-020-00323-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gerges SH, El-Kadi AOS. Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases. Pharmacol Ther 2021;:108046. [PMID: 34808133 DOI: 10.1016/j.pharmthera.2021.108046] [Reference Citation Analysis]
21 Laughlin-Tommaso SK, Fuchs EL, Wellons MF, Lewis CE, Calderon-Margalit R, Stewart EA, Schreiner PJ. Uterine Fibroids and the Risk of Cardiovascular Disease in the Coronary Artery Risk Development in Young Adult Women's Study. J Womens Health (Larchmt) 2019;28:46-52. [PMID: 30412447 DOI: 10.1089/jwh.2018.7122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Maas AHEM, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H, Kunadian V, Laan E, Lambrinoudaki I, Maclaran K, Panay N, Stevenson JC, van Trotsenburg M, Collins P. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J 2021;42:967-84. [PMID: 33495787 DOI: 10.1093/eurheartj/ehaa1044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
23 Sun D, Wu Y, Ding M, Zhu F. Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome. Angiology 2022;:33197211072598. [PMID: 35258380 DOI: 10.1177/00033197211072598] [Reference Citation Analysis]
24 Woodward HJ, Zhu D, Hadoke PWF, MacRae VE. Regulatory Role of Sex Hormones in Cardiovascular Calcification. Int J Mol Sci 2021;22:4620. [PMID: 33924852 DOI: 10.3390/ijms22094620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mahboobifard F, Rahmati M, Niknam A, Rojhani E, Momenan AA, Azizi F, Ramezani Tehrani F. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study. Arch Med Res 2021:S0188-4409(21)00221-6. [PMID: 34823887 DOI: 10.1016/j.arcmed.2021.11.001] [Reference Citation Analysis]
26 Meun C, Gunning MN, Louwers YV, Peters H, Roos-Hesselink J, Roeters van Lennep J, Rueda Ochoa OL, Appelman Y, Lambalk N, Boersma E, Kavousi M, Fauser BC, Laven JS; CREW consortium. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2020;92:150-8. [PMID: 31638273 DOI: 10.1111/cen.14117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
27 Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol 2018;315:H1569-88. [PMID: 30216121 DOI: 10.1152/ajpheart.00396.2018] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 15.8] [Reference Citation Analysis]
28 Bajuk Studen K, Pfeifer M. Cardiometabolic risk in polycystic ovary syndrome. Endocr Connect. 2018;7:R238-R251. [PMID: 29844207 DOI: 10.1530/ec-18-0129] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
29 Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, Moran LJ, Avery JC, McEvoy RD, Davies MJ. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat Sci Sleep 2018;10:45-64. [PMID: 29440941 DOI: 10.2147/NSS.S127475] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 7.8] [Reference Citation Analysis]
30 Penn CA, Chan J, Mesaros C, Snyder NW, Rader DJ, Sammel MD, Dokras A. Association of serum androgens and coronary artery calcium scores in women. Fertil Steril 2019;112:586-93. [PMID: 31200968 DOI: 10.1016/j.fertnstert.2019.04.024] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
31 Prabakaran S, Schwartz A, Lundberg G. Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use. Ther Adv Endocrinol Metab 2021;12:20420188211013917. [PMID: 34104397 DOI: 10.1177/20420188211013917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lin AW, Siscovick D, Sternfeld B, Schreiner P, Lewis CE, Wang ET, Merkin SS, Wellons M, Steffen L, Calderon-Margalit R, Cassano PA, Lujan ME. Associations of diet, physical activity and polycystic ovary syndrome in the Coronary Artery Risk Development in Young Adults Women's Study. BMC Public Health 2021;21:35. [PMID: 33407255 DOI: 10.1186/s12889-020-10028-5] [Reference Citation Analysis]
33 Uçkan K, Demir H, Turan K, Sarıkaya E, Demir C, Berezin A. Role of Oxidative Stress in Obese and Nonobese PCOS Patients. International Journal of Clinical Practice 2022;2022:1-9. [DOI: 10.1155/2022/4579831] [Reference Citation Analysis]
34 Patil CN, Racusen LC, Reckelhoff JF. Consequences of advanced aging on renal function in chronic hyperandrogenemic female rat model: implications for aging women with polycystic ovary syndrome. Physiol Rep 2017;5:e13461. [PMID: 29051304 DOI: 10.14814/phy2.13461] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]